drugset / Trial / NCT00681798
Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to define th Maximum Tolerated Dose (MTD) and the recommended dose (RD) of ZD6474 in combination with a fixed standard dose of gemcitabine and capecitabine
Timeline
- Start
- 2006-07
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vandetanib | Small molecule | 100 mg | — |
| Comparator | Vandetanib | Small molecule | 300 mg | — |